VTYX: Ventyx Biosciences Inc. Kompaniya qiymatining sof foydaga nisbati
Ventyx Biosciences (VTYX) kompaniyasining moliyaviy narxlar grafigi -9.30 qiymatini ko'rsatmoqda. Biznesning muvaffaqiyati yangi molekulalarning klinik sinovlari natijalariga bog'liq, asosiy aksiyadorlarning qo'llab-quvvatlashi esa naqd pul risklarini minimallashtiradi. Ventyx Biosciences (VTYX) og'iz orqali qabul qilinadigan yallig'lanishga qarshi davolash vositalarini ishlab chiqmoqda va pul oqimini barqarorlashtirish uchun sanoat gigantlari bilan hamkorlikdan foydalanmoqda. O'sish istiqbollari patent himoyasi hamda autoimmun patologiyalarni davolashda qo'llaniladigan terapiyalarning xavfsizligi bilan belgilanadi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_VTYX_-_Ventyx-Biosciences_-_PE-Multiple "VTYX: Ventyx Biosciences Biznesning o‘zini qoplash muddati 22.08.2022 - 14.03.2026 | 👁️GURU.Markets👁️")
Ventyx Bio (VTYX) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Ventyx Biosciences|VTYX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Ventyx Biosciences, Inc|VTYX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Ventyx Biosciences, Inc.|VTYX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Ventyx Biosciences|Tezkor likvidlik ventyxbio.com
- foyda va bozor multiplikatorlari tafsilotlari:
VTYX - Sof foyda|Kutilayotgan sof foyda Ventyx Biosciences|VTYX - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati Ventyx Biosciences Inc.|VTYX - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Ventyx Biosciences, Inc.|VTYX - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Ventyx Biosciences|VTYX - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi ventyxbio.com|VTYX - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Ventyx Biosciences
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:ventyxbio.com VTYX
Professional aktivlarni tanlash emitentlarni baholash koeffitsientlari asosida filtrlashdan boshlanadi. Ushbu ko'rsatkich bozor kapitalizatsiyasini sof foyda bilan bog'lab, biznes bahosining qarz olish xarajatlariga va kelajakdagi oqimlarning diskontlanishiga bo'lgan sezgirligini aks ettiradi. Ventyx Biosciences (VTYX) uchun ushbu hisob-kitob M&A salohiyatini va kichik molekulali klinik sinovlarning muvaffaqiyatini baholashda hal qiluvchi ahamiyatga ega. Jori narx-foyda nisbatini tahlil qilish orqali investor aksiyalarning fundamental o'sish omillariga nisbatan qanchalik hadda qimmat baholanganligini aniqlaydi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL: Narx-foyda koeffitsiyenti|TRML: Narxning foydaga nisbati|PGEN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati pharming.com (PHAR)|Narxning foydaga nisbati Nektar Therapeutics Inc.|Narx-foyda multiplikatori UPB (Upstream Bio, Inc.)|Narx-foyda koeffitsiyenti ZBIO (Zenas Biopharma, Inc.)|Bozor narxining sof foydaga nisbati IMNM|Gossamer Bio, Inc. - Narx-foyda koeffitsiyenti|kalvista.com (KALV) - Kapitalizatsiyaning foydaga nisbati|SEPN: Narx-foyda koeffitsiyenti|PVLA (Pieris Pharma) - Narx-foyda multiplikatori|SVRA (Savara Corp) - Narx-foyda koeffitsiyenti|Rigel Corp - Kompaniya qiymatining sof foydaga nisbati|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|Narxning foydaga nisbati ATXS|P/E multiplikatori ENGN|Biznesning o‘zini qoplash muddati RAPT Therapeutics Inc.|Narxning foydaga nisbati Aerovate Therapeutics JBIO|Aclaris Therapeutics, Inc (ACRS) - Kapitalizatsiyaning foydaga nisbati|KYTX - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati tizianalifesciences.com TLSA|CABA: P/E multiplikatori|Narx-foyda koeffitsiyenti Theratechnologies, Inc.|AVTX (Avalo Therapeutics Inc.) - P/E multiplikatori|Eledon Pharmaceuticals, Inc (ELDN) - Biznesning o‘zini qoplash muddati|P/E multiplikatori AGEN|CLYM - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Zura Bio ZURA|ATYR: Narx-foyda multiplikatori|Adagene Corp - P/E multiplikatori|ImageneBio Inc (IMA) - Narx-foyda koeffitsiyenti|STTK: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Equillium (EQ)|Narxning foydaga nisbati Connect Biopharma Holdings|Immunic Inc (IMUX) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ATRA (Atara Biotherapeutics)|Narxning foydaga nisbati IFRX (inflarx.de)|X4 Pharmaceuticals - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati ACET (Adicet Bio Inc.)|CELU: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati INmune Bio Inc|BRNS (Barinthus Bio) - Narx-foyda koeffitsiyenti|Narx-foyda multiplikatori KZR|Narxning foydaga nisbati SAB Biotherapeutics|akaritx.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ENLV|QTTB (q32bio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GOVX (GeoVax Labs Inc)|P/E multiplikatori Edesa Biotech Corp EDSA|IBIO - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati CARM (Carisma Therapeutics)|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Bolt Biotherapeutics, Inc.|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|P/E multiplikatori Aptevo|Narx-foyda koeffitsiyenti AIM (AIM ImmunoTech Inc.)|ADTX (aditxt.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GRI (GRI Bio)|Biznesning o‘zini qoplash muddati XORTX Therapeutics Inc (XRTX)|HIND - Narxning foydaga nisbati|Revelation Biosciences Corp (REVB) - Narx-foyda koeffitsiyenti|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti scinai.com|Narx-foyda koeffitsiyenti CALI|P/E multiplikatori Affimed Therapeutics|Narxning foydaga nisbati Allakos Inc. (ALLK)|hookipapharma.com - Narx-foyda multiplikatori|P/E multiplikatori IGMS (IGM Biosciences)|iteostherapeutics.com (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|TCBP: Narxning foydaga nisbati|THRD: P/E multiplikatori
